Mutagenetix > Incidental Mutation

Incidental Mutation 'R0103:Entpd5'

34495

Institutional Source

Beutler Lab

Gene Symbol

Entpd5

Ensembl Gene

ENSMUSG00000021236

Gene Name

ectonucleoside triphosphate diphosphohydrolase 5

Synonyms

Pcph, NTPDase-5, mNTPase, ER-UDPase, NTPDase5, Cd39l4

MMRRC Submission

038389-MU

Accession Numbers

Essential gene?

Non essential (E-score: 0.000) question?

Stock #

R0103 (G1)

Quality Score

225

Status

Validated (trace)

Chromosome

Chromosomal Location

84420649-84455803 bp(-) (GRCm39)

Type of Mutation

nonsense

DNA Base Change (assembly)

C to A at 84443717 bp (GRCm39)

Zygosity

Heterozygous

Amino Acid Change

Glutamic Acid to Stop codon at position 9 (E9*)

Ref Sequence

ENSEMBL: ENSMUSP00000071939 (fasta)

Gene Model

predicted gene model for transcript(s): [ENSMUST00000021662] [ENSMUST00000072061] [ENSMUST00000110272] [ENSMUST00000117286] [ENSMUST00000120942] [ENSMUST00000122194]

AlphaFold

Q9WUZ9

Predicted Effect

probably benign
Transcript: ENSMUST00000021662

SMART Domains

Protein: ENSMUSP00000021662
Gene: ENSMUSG00000021236

Domain	Start	End	E-Value	Type
signal peptide	1	18	N/A	INTRINSIC
Pfam:GDA1_CD39	41	426	3.5e-76	PFAM

Predicted Effect

probably null
Transcript: ENSMUST00000072061
AA Change: E9*

SMART Domains

Protein: ENSMUSP00000071939
Gene: ENSMUSG00000021236
AA Change: E9*

Domain	Start	End	E-Value	Type
transmembrane domain	27	46	N/A	INTRINSIC
Pfam:GDA1_CD39	65	451	1.9e-77	PFAM

Predicted Effect

probably benign
Transcript: ENSMUST00000110272

SMART Domains

Protein: ENSMUSP00000105901
Gene: ENSMUSG00000021236

Domain	Start	End	E-Value	Type
signal peptide	1	18	N/A	INTRINSIC
Pfam:GDA1_CD39	41	426	3.5e-76	PFAM

Predicted Effect

probably benign
Transcript: ENSMUST00000117286

SMART Domains

Protein: ENSMUSP00000114011
Gene: ENSMUSG00000021236

Domain	Start	End	E-Value	Type
signal peptide	1	18	N/A	INTRINSIC
Pfam:GDA1_CD39	41	426	3.5e-76	PFAM

Predicted Effect

probably benign
Transcript: ENSMUST00000120942

SMART Domains

Protein: ENSMUSP00000112516
Gene: ENSMUSG00000021236

Domain	Start	End	E-Value	Type
signal peptide	1	18	N/A	INTRINSIC
Pfam:GDA1_CD39	41	426	3.5e-76	PFAM

Predicted Effect

probably benign
Transcript: ENSMUST00000122194

SMART Domains

Protein: ENSMUSP00000113106
Gene: ENSMUSG00000021236

Domain	Start	End	E-Value	Type
signal peptide	1	18	N/A	INTRINSIC
Pfam:GDA1_CD39	41	426	3.5e-76	PFAM

Meta Mutation Damage Score

0.9755

Coding Region Coverage

1x: 99.3%
3x: 98.6%
10x: 97.0%
20x: 94.8%

Validation Efficiency

99% (84/85)

MGI Phenotype

FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is similar to E-type nucleotidases (NTPases)/ecto-ATPase/apyrases. NTPases, such as CD39, mediate catabolism of extracellular nucleotides. ENTPD5 contains 4 apyrase-conserved regions which is characteristic of NTPases. [provided by RefSeq, Jan 2009]
PHENOTYPE: Mice homozygous for a null allele develop progressive hepatopathy, hepatocellular tumors, and spermatogenic arrest. [provided by MGI curators]

Allele List at MGI

Other mutations in this stock

Total: 84 list
Gene	Ref	Var	Chr/Loc	Mutation	Predicted Effect	Zygosity
Abca13	A	C	11: 9,223,951 (GRCm39)	R443S	probably damaging	Het
Anapc1	T	C	2: 128,522,372 (GRCm39)		probably benign	Het
Aqr	T	A	2: 113,979,497 (GRCm39)	I313F	probably damaging	Het
Arfgap3	A	T	15: 83,206,922 (GRCm39)		probably benign	Het
Asah2	G	T	19: 31,996,377 (GRCm39)	H374N	probably benign	Het
Avl9	G	T	6: 56,713,468 (GRCm39)	R242L	probably benign	Het
Ccdc106	C	A	7: 5,060,544 (GRCm39)	Q35K	probably benign	Het
Ccm2l	G	T	2: 152,909,839 (GRCm39)	E64*	probably null	Het
Cep85l	A	T	10: 53,154,270 (GRCm39)	D776E	possibly damaging	Het
Cfap52	T	A	11: 67,815,951 (GRCm39)	I611F	possibly damaging	Het
Cldn22	C	T	8: 48,277,589 (GRCm39)	T9M	probably benign	Het
Coa7	T	C	4: 108,195,338 (GRCm39)	L89P	possibly damaging	Het
Cox7a2l	A	T	17: 83,821,701 (GRCm39)	Y2N	probably damaging	Het
Ctns	A	C	11: 73,076,137 (GRCm39)	I299M	probably damaging	Het
Cyp27a1	A	C	1: 74,775,074 (GRCm39)	E301A	probably benign	Het
Cyp2b13	A	T	7: 25,788,135 (GRCm39)	K421M	probably damaging	Het
Cyp4f40	G	T	17: 32,895,282 (GRCm39)	C468F	probably damaging	Het
Cyp4f40	C	A	17: 32,895,283 (GRCm39)	C468*	probably null	Het
Dcun1d5	G	A	9: 7,188,788 (GRCm39)	C74Y	probably damaging	Het
Dennd4c	A	G	4: 86,730,683 (GRCm39)	Y860C	probably benign	Het
Dgkz	T	C	2: 91,764,550 (GRCm39)	T1028A	probably benign	Het
Dhx58	T	C	11: 100,586,096 (GRCm39)	T642A	probably damaging	Het
Dlg4	A	G	11: 69,922,019 (GRCm39)	Y87C	probably damaging	Het
Dnah6	C	T	6: 73,069,155 (GRCm39)	E2511K	probably damaging	Het
Fbln2	A	C	6: 91,248,532 (GRCm39)	I1066L	probably benign	Het
Fhl2	C	T	1: 43,192,381 (GRCm39)	R4H	probably benign	Het
Frmpd1	T	A	4: 45,229,884 (GRCm39)	I17K	probably damaging	Het
Galnt2l	A	G	8: 122,996,472 (GRCm39)		probably benign	Het
Gbp7	T	A	3: 142,252,299 (GRCm39)	N627K	probably benign	Het
Gnptab	A	G	10: 88,265,381 (GRCm39)	Y331C	probably damaging	Het
Hdac4	T	C	1: 91,903,366 (GRCm39)	E521G	possibly damaging	Het
Hibadh	T	A	6: 52,534,862 (GRCm39)	M173L	probably benign	Het
Iba57	C	T	11: 59,054,439 (GRCm39)	A27T	probably benign	Het
Itga1	T	C	13: 115,152,790 (GRCm39)	I211V	probably benign	Het
Keg1	A	T	19: 12,696,280 (GRCm39)	I155F	possibly damaging	Het
Krt84	T	C	15: 101,438,671 (GRCm39)	E272G	probably damaging	Het
Lrp2	C	A	2: 69,307,384 (GRCm39)	V2892L	probably benign	Het
Ltb	A	G	17: 35,414,016 (GRCm39)		probably benign	Het
Masp1	G	A	16: 23,276,768 (GRCm39)	P579L	probably damaging	Het
Mtor	T	A	4: 148,618,359 (GRCm39)	M1724K	probably benign	Het
Myo3a	T	G	2: 22,436,360 (GRCm39)		probably benign	Het
Myo9b	C	T	8: 71,776,493 (GRCm39)		probably benign	Het
Ncor1	G	T	11: 62,233,871 (GRCm39)	Q444K	possibly damaging	Het
Nek7	A	T	1: 138,471,980 (GRCm39)	C53*	probably null	Het
Obscn	G	T	11: 58,953,522 (GRCm39)	Y4044*	probably null	Het
Or5b105	G	A	19: 13,080,642 (GRCm39)	R3C	possibly damaging	Het
Pcdh15	A	T	10: 74,046,257 (GRCm39)	D178V	probably damaging	Het
Pcsk6	T	C	7: 65,578,845 (GRCm39)		probably benign	Het
Phxr4	T	C	9: 13,343,087 (GRCm39)		probably benign	Het
Pkhd1	T	A	1: 20,593,583 (GRCm39)	D1510V	probably benign	Het
Pkhd1l1	T	C	15: 44,460,537 (GRCm39)	C4249R	probably benign	Het
Plxnb2	A	G	15: 89,045,972 (GRCm39)	Y968H	possibly damaging	Het
Prpf39	T	C	12: 65,102,057 (GRCm39)	V378A	possibly damaging	Het
Psd2	A	G	18: 36,137,770 (GRCm39)	N455S	probably damaging	Het
Ptch2	C	A	4: 116,966,622 (GRCm39)		probably benign	Het
Rab4b	A	G	7: 26,873,927 (GRCm39)	I117T	probably benign	Het
Rad9b	A	T	5: 122,469,590 (GRCm39)	V348E	probably damaging	Het
Rcor1	T	C	12: 111,076,212 (GRCm39)		probably benign	Het
Rhoc	A	T	3: 104,699,307 (GRCm39)	E32V	possibly damaging	Het
Rnf40	T	G	7: 127,199,743 (GRCm39)	V925G	probably damaging	Het
Rptor	G	T	11: 119,775,793 (GRCm39)	R988L	probably benign	Het
Slc25a32	A	T	15: 38,963,292 (GRCm39)	Y176*	probably null	Het
Slc7a1	T	A	5: 148,289,236 (GRCm39)	K4*	probably null	Het
Ss18	A	C	18: 14,812,478 (GRCm39)	Y38D	probably damaging	Het
Syt4	T	A	18: 31,580,273 (GRCm39)		probably benign	Het
Taar4	A	T	10: 23,837,304 (GRCm39)	N305Y	probably damaging	Het
Taar7b	A	T	10: 23,876,192 (GRCm39)	Y119F	probably benign	Het
Tcaf1	G	T	6: 42,663,324 (GRCm39)	D185E	probably benign	Het
Tmem138	T	C	19: 10,552,316 (GRCm39)	N62S	possibly damaging	Het
Tnfaip2	C	T	12: 111,412,244 (GRCm39)	T215M	probably benign	Het
Tnfrsf21	C	T	17: 43,349,104 (GRCm39)	H239Y	probably benign	Het
Tnfrsf25	C	T	4: 152,201,405 (GRCm39)	P65S	possibly damaging	Het
Trp53bp1	A	T	2: 121,067,240 (GRCm39)	S495R	possibly damaging	Het
Trpv3	T	C	11: 73,184,805 (GRCm39)	F597S	probably damaging	Het
Tsc22d4	A	C	5: 137,745,378 (GRCm39)	M1L	possibly damaging	Het
Ttc39a	A	G	4: 109,278,650 (GRCm39)		probably null	Het
Ttn	T	G	2: 76,591,570 (GRCm39)	H21033P	probably damaging	Het
Ugt2a3	A	G	5: 87,484,577 (GRCm39)	V149A	possibly damaging	Het
Ush2a	T	G	1: 188,051,267 (GRCm39)	I251R	possibly damaging	Het
Vamp4	T	C	1: 162,417,108 (GRCm39)	C114R	possibly damaging	Het
Wdr33	T	C	18: 31,966,388 (GRCm39)	V135A	probably damaging	Het
Zc3h13	T	A	14: 75,567,908 (GRCm39)	V1067E	probably damaging	Het
Zcwpw1	G	A	5: 137,808,375 (GRCm39)	W274*	probably null	Het
Zfp219	T	A	14: 52,244,163 (GRCm39)	H627L	probably damaging	Het

Other mutations in Entpd5

Allele	Source	Chr	Coord	Type	Predicted Effect	PPH Score
IGL00924:Entpd5	APN	12	84,433,828 (GRCm39)	missense	probably damaging	1.00
IGL01455:Entpd5	APN	12	84,441,451 (GRCm39)	missense	probably benign	0.00
IGL02168:Entpd5	APN	12	84,433,752 (GRCm39)	critical splice donor site	probably null
IGL02183:Entpd5	APN	12	84,427,154 (GRCm39)	splice site	probably benign
IGL03104:Entpd5	APN	12	84,431,022 (GRCm39)	missense	probably damaging	0.97
IGL03332:Entpd5	APN	12	84,429,002 (GRCm39)	splice site	probably null
aventi	UTSW	12	84,429,069 (GRCm39)	nonsense	probably null
eatsy	UTSW	12	84,429,069 (GRCm39)	nonsense	probably null
magenschonend	UTSW	12	84,441,464 (GRCm39)	missense	probably benign	0.00
R0024:Entpd5	UTSW	12	84,420,507 (GRCm39)	missense	probably benign	0.01
R0103:Entpd5	UTSW	12	84,443,717 (GRCm39)	nonsense	probably null
R0644:Entpd5	UTSW	12	84,432,915 (GRCm39)	missense	probably benign	0.00
R1533:Entpd5	UTSW	12	84,441,434 (GRCm39)	missense	probably damaging	1.00
R1536:Entpd5	UTSW	12	84,429,069 (GRCm39)	nonsense	probably null
R1740:Entpd5	UTSW	12	84,443,545 (GRCm39)	missense	probably benign	0.01
R1768:Entpd5	UTSW	12	84,432,985 (GRCm39)	missense	probably benign
R2049:Entpd5	UTSW	12	84,443,632 (GRCm39)	missense	probably benign	0.00
R5128:Entpd5	UTSW	12	84,441,464 (GRCm39)	missense	probably benign	0.00
R6562:Entpd5	UTSW	12	84,432,974 (GRCm39)	missense	probably damaging	1.00
R6907:Entpd5	UTSW	12	84,424,127 (GRCm39)	missense	probably benign	0.23
R7209:Entpd5	UTSW	12	84,443,702 (GRCm39)	missense	probably benign
R7605:Entpd5	UTSW	12	84,443,482 (GRCm39)	missense	probably damaging	1.00
R8700:Entpd5	UTSW	12	84,443,508 (GRCm39)	missense	probably damaging	1.00
X0057:Entpd5	UTSW	12	84,430,994 (GRCm39)	splice site	probably null

Predicted Primers

PCR Primer
(F):5'- GTGCTGCCCGCATCAAACATAATTC -3'
(R):5'- TTGTGCTCGATCCACTGTGTCAG -3'

Sequencing Primer
(F):5'- ACATAATTCCATAAAAGGTGCCG -3'
(R):5'- tgggaggtgcaggaagg -3'

Posted On

2013-05-09